CYP2R1
Basic information
Region (hg38): 11:14877440-14892231
Links
Phenotypes
GenCC
Source:
- vitamin D-dependent rickets, type 1 (Supportive), mode of inheritance: AR
- vitamin D hydroxylation-deficient rickets, type 1B (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Vitamin D hydroxylation deficient rickets, type 1B | AR | Endocrine | Medical treatment (eg, with supraphysiological levels of vitamin D3 or D2) has been reported to result in improvement or resolution of biochemical and clinical/radiographic anomalies | Endocrine | 8201479; 15128933; 22855339 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (150 variants)
- Vitamin_D_hydroxylation-deficient_rickets,_type_1B (98 variants)
- not_specified (50 variants)
- CYP2R1-related_disorder (5 variants)
- Low_serum_calcitriol (1 variants)
- Vitamin_D-dependent_rickets,_type_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2R1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024514.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 47 | 50 | ||||
missense | 126 | 133 | ||||
nonsense | 14 | |||||
start loss | 1 | 1 | ||||
frameshift | 9 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 12 | 15 | 132 | 52 | 0 |
Highest pathogenic variant AF is 0.000192725
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP2R1 | protein_coding | protein_coding | ENST00000334636 | 5 | 14246 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.79e-10 | 0.327 | 125604 | 0 | 144 | 125748 | 0.000573 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.481 | 247 | 269 | 0.918 | 0.0000129 | 3284 |
Missense in Polyphen | 83 | 116.68 | 0.71134 | 1441 | ||
Synonymous | -0.468 | 106 | 100 | 1.06 | 0.00000466 | 969 |
Loss of Function | 0.899 | 17 | 21.5 | 0.791 | 0.00000134 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00229 | 0.00227 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000608 | 0.000598 |
Finnish | 0.0000926 | 0.0000924 |
European (Non-Finnish) | 0.000455 | 0.000422 |
Middle Eastern | 0.000608 | 0.000598 |
South Asian | 0.000396 | 0.000392 |
Other | 0.000673 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Has a D-25-hydroxylase activity on both forms of vitamin D, vitamin D(2) and D(3). {ECO:0000269|PubMed:12867411, ECO:0000269|PubMed:15465040, ECO:0000269|PubMed:18511070}.;
- Disease
- DISEASE: Rickets vitamin D-dependent 1B (VDDR1B) [MIM:600081]: An autosomal recessive disorder caused by a selective deficiency of the active form of vitamin D (1,25-dihydroxyvitamin D3) and resulting in defective bone mineralization and clinical features of rickets. The patients sera have low calcium concentrations, low phosphate concentrations, elevated alkaline phosphatase activity and low levels of 25-hydroxyvitamin D. {ECO:0000269|PubMed:15128933, ECO:0000269|PubMed:25942481}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Steroid biosynthesis - Homo sapiens (human);Vitamin D Metabolism;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Vitamins;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Metabolism of steroids;Vitamin D (calciferol) metabolism;bile acid biosynthesis, neutral pathway;vitamin D<sub>3</sub> biosynthesis;Steroid hormones
(Consensus)
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- loftool
- 0.669
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.92
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.186
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp2r1
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- cyp2r1
- Affected structure
- subcutaneous fat
- Phenotype tag
- abnormal
- Phenotype quality
- increased amount
Gene ontology
- Biological process
- organic acid metabolic process;vitamin metabolic process;xenobiotic metabolic process;response to cesium ion;response to ionizing radiation;calcitriol biosynthetic process from calciol;vitamin D metabolic process;exogenous drug catabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- iron ion binding;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;vitamin D3 25-hydroxylase activity